ZANOVELLO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.087
EU - Europa 1.256
AS - Asia 761
SA - Sud America 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.072
CN - Cina 634
DE - Germania 267
IT - Italia 254
FI - Finlandia 233
SE - Svezia 178
UA - Ucraina 147
GB - Regno Unito 113
VN - Vietnam 81
IN - India 27
IE - Irlanda 16
CA - Canada 15
FR - Francia 13
HK - Hong Kong 10
CH - Svizzera 9
RU - Federazione Russa 7
NL - Olanda 5
BR - Brasile 4
RO - Romania 4
AU - Australia 3
EU - Europa 3
JP - Giappone 3
SG - Singapore 3
CL - Cile 2
DK - Danimarca 2
KR - Corea 2
NZ - Nuova Zelanda 2
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.120
Salva come PNG Salva come JPEG
Città #
Fairfield 1.641
Woodbridge 1.403
Houston 1.106
Chandler 1.009
Ann Arbor 983
Ashburn 711
Jacksonville 638
Seattle 588
Wilmington 583
Cambridge 569
Princeton 275
San Diego 223
Beijing 192
Padova 156
Nanjing 117
Des Moines 112
Helsinki 85
Boardman 81
Dong Ket 81
Roxbury 78
Medford 76
Hebei 41
Guangzhou 40
Nanchang 37
Norwalk 26
Shenyang 26
New York 24
London 23
Munich 22
Changsha 21
Jiaxing 21
Kharkiv 18
Tianjin 18
Dublin 15
Jinan 15
Los Angeles 14
Falls Church 13
Milan 13
Nürnberg 13
Ogden 13
Washington 13
Borås 12
Detroit 12
Dearborn 11
Redwood City 11
Hong Kong 10
Kilburn 9
Pune 7
Rockville 7
San Francisco 7
Indiana 6
Portadown 6
Rome 6
Chicago 5
Hefei 5
Hounslow 5
Ningbo 5
Shanghai 5
Tappahannock 5
Zurich 5
Chengdu 4
Chiswick 4
Kunming 4
Phoenix 4
Toulouse 4
Yellow Springs 4
Zhengzhou 4
Americana 3
Auburn Hills 3
Belfast 3
Berlin 3
Costa Mesa 3
Elmas 3
Genoa 3
Haikou 3
Hanover 3
Hyderabad 3
Lanzhou 3
North York 3
Ottawa 3
Prescot 3
St Petersburg 3
Sydney 3
Ascoli Piceno 2
Bologna 2
Caltignaga 2
Cislago 2
Columbus 2
Copenhagen 2
Dallas 2
Dolo 2
Edinburgh 2
Hangzhou 2
Kiel 2
La Canada Flintridge 2
Las Vegas 2
New Bedfont 2
Orange 2
Orsay 2
Paris 2
Totale 11.382
Salva come PNG Salva come JPEG
Nome #
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 170
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. 169
Cellular pharmacology of PNU-159682, a liver microsomal metabolite of methoxymorpholinyl doxorubicin (Nemorubicin; MMDX) 166
Reverse immunoediting: When immunity is edited by antigen 164
A circulating miRNA assay as a first-line test for prostate cancer screening 158
Immunogenetic aspects of erosive osteoarthritis of the hand in patients from northern Italy 136
WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia 136
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer 132
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors 131
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells 129
Cancer rejection by the immune system: forcing the check-points of tumor immune escape. 128
A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity. 128
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST) 127
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis 124
DNA immunization in mice against virus-induced tumor antigens. 124
Formation and antitumor activity of PNU-159682, a major metabolite of nemorubicin in human liver microsomes 122
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area 121
MiR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis 120
Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate 117
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer 116
Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus. 115
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization 113
Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS Patients 113
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: Experimental set-up and inference method 111
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells 111
DNA-based vaccination against tumors expressing the P1A antigen 111
Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells 108
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 107
Myeloid-derived suppressor cell role in tumor-related inflammation 106
HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer 106
Immunotherapy for EBV-associated malignancies 106
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer 106
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells 104
Lack of M-MuSV tumour regression associated with T lymphocyte tolerance. 102
Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase. 102
Role of infectious virus expression and immune response in retrovirus-induced oncogenesis. 101
CTL Analysis for Tumor Vaccines. 101
Human miRNome profiling in colorectal cancer and liver metastasis development 101
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 101
Role of microRNAs in HTLV-1 infection and transformation 100
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer 100
Derangement of immune responses by myeloid suppressor cells 99
Regulation of immune responses by L- arginine metabolism 99
Role of arginine metabolism in immunity and immunopathology. 99
L-arginine metabolism in myeloid cells controls T-lymphocyte functions 98
Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors. 97
INHIBITION OF PROTEIN-TYROSINE PHOSPHORYLATION PREVENTS T-CELL-MEDIATED CYTOTOXICITY 95
Myeloid-derived suppressor cell heterogeneity and subset definition 95
Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate. 95
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase. 94
Characterization of Clinical and Molecular Features Related to the Downregulated Expression of μ-Protocadherin in Colorectal Cancer. 94
Extracellular ATP as a possible mediator of cell-mediated cytotoxicity 93
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention 93
Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus. 93
Reprogramming T Lymphocytes for Melanoma Adoptive Immunotherapy by T-Cell Receptor Gene Transfer with Lentiviral Vectors 92
Adoptive cell therapy against EBV-related malignancies: a survey of clinical results 92
Study of Some Early Immunological Parameters In Aging Humans 92
A gene expression signature associated with survival in metastatic melanoma 91
CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A. 91
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination 90
A paclitaxel-hyaluronan bioconjugate exerts a high in vivo therapeutic activity against ovarian cancer 90
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 90
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPbeta Transcription Factor. 89
An integrative framework identifies alternative splicing events in colorectal cancer development. 89
CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes 88
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases 87
Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow 87
Calcium and Inositolphosphates In the Activation of T-cell-mediated Cytotoxicity 87
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 86
Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel 85
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer 85
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150 85
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies 85
T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy 84
MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas 84
Tumor-induced immune dysfunctions caused by myeloid suppressor cells 83
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice 83
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 82
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes 82
Impact of gamma-chain cytokines on EBV-specific T cell cultures 82
Dissecting the molecular regulatory networks in human myeloid-derived suppressor cells 82
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma 81
Common cancer biomarkers 81
Therapeutical effect of 4′-deoxy-4′-iododoxorubicin-loaded LAK cells in mice bearing lung metastases 80
ANTITUMOR EFFICACY OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH RICIN AGAINST EXPERIMENTALLY INDUCED LUNG METASTASES 80
Melanoma-restricted genes 80
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy 79
Inhibition of CTLI-line lysis after gangliosides treatment 78
ADOPTIVE TRANSFER OF LYMPHOKINE-ACTIVATED KILLER-CELLS LOADED WITH 4'-DEOXY-4'-IODODOXORUBICIN - THERAPEUTIC EFFECT IN MICE BEARING LUNG METASTASES 78
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism 78
Synergistic effect of extracellular adenosine 5-triphosphate and tumor necrosis factor on DNA degradation 77
Functional activityin vivo of effector T cell populations III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone 77
Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes. 77
Chemotactic Cues for NOTCH1-Dependent Leukemia 76
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models. 75
Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient 75
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination 75
Therapeutic effectiveness of recombinant cancer vaccines is associated with prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes 74
Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice. 74
Peritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugs. 74
Totale 9.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.239
article - articoli 41.158
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 460
Totale 83.857
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019969 0 0 0 0 0 0 0 0 0 212 418 339
2019/20202.711 398 100 53 199 274 221 249 314 281 320 183 119
2020/20211.725 90 154 83 133 79 123 59 198 244 184 201 177
2021/20222.385 68 302 350 146 80 164 201 214 87 47 290 436
2022/20231.901 403 234 56 232 290 259 10 116 187 15 68 31
2023/2024678 48 107 91 55 84 100 73 62 31 27 0 0
Totale 13.189